MarketBeat
08 Nov 2026, 08:14 UTC · 4h ago
Teleflex Q3 Earnings Call Highlights
Impact · against what's priced in
Teleflex raises its 2026 EPS guidance to a midpoint of $7.63, providing a tangible near-term catalyst despite a significant portion of the Q3 beat being driven by a non-recurring tariff refund. The potential slip of the Intersurgical divestiture into 2027 creates a headwind for the timing of margin expansion and cash infusion.
- TFX+0.40
No priced-in read yet
- In context
The company raised its 2026 adjusted EPS outlook to $7.50-$7.75 from $6.90-$7.20, though the Q3 beat was heavily supported by a $16.5 million tariff refund. Potential delays in the Intersurgical divestiture due to an FTC second request could push the targeted 23% operating margin realization into 2027.
